Description

Brovanexine is a synthetic chemical compound with significant therapeutic potential, primarily recognized for its mucolytic and expectorant properties. Its core value lies in its ability to effectively manage respiratory conditions by reducing mucus viscosity and facilitating airway clearance. This makes it a critical intermediate or active ingredient for pharmaceutical manufacturers targeting the development of advanced respiratory medications. Industries requiring high-purity chemical synthesis for drug development are the primary users of this compound.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of prescription mucolytic and expectorant drugs.
• Respiratory Drug Formulation: Used in R&D and production of medications for chronic bronchitis, asthma, and COPD (Chronic Obstructive Pulmonary Disease).
• Active Pharmaceutical Ingredient (API): Can be formulated as the primary active component in cough syrups, tablets, and other oral dosage forms.
• Research & Development: Employed in preclinical and clinical studies to explore new therapeutic applications and delivery mechanisms.
• Reference Standard: Used in analytical laboratories as a high-purity standard for quality control and method validation of related pharmaceutical products.

Basic Information

Product Name	Brovanexine
CAS No.	54340-61-3
Molecular Formula	C13H20N2O2
Molecular Weight	236.31 g/mol
Synonyms	Brovanexine; Brovan; Brovaxine; N-Cyclohexyl-N-methyl-2-amino-3,5-dibromobenzylamine; 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzylamine; 3,5-Dibromo-2-(N-cyclohexyl-N-methylaminomethyl)aniline; Brovanexinum [Latin]; BRL 10833
EINECS	Contact for details

Quality Control

Our Brovanexine is manufactured under a strict quality management system to ensure batch-to-batch consistency and high purity suitable for pharmaceutical applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP (current Good Manufacturing Practice) guidelines where applicable, and our quality protocols are designed to meet the stringent requirements of global pharmacopoeial standards.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.0%
Related Substances (HPLC)	Total impurities ≤2.0%
Loss on Drying	≤0.5%
Residue on Ignition	≤0.1%
Heavy Metals	≤20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.